Accelerator Fund boon to research

Tuesday, January 5, 2010 - 16:28 in Mathematics & Economics

Sometimes, promising scientific findings aren’t enough, by themselves. Life-science researchers at Harvard who’ve made new inventions with applied and commercial potential are often disappointed to learn that pharmaceutical, venture capital, or biotech firms aren’t interested in their work — and not because a discovery lacks merit. Instead, the glitch may be that the research hasn’t progressed far enough to establish proof-of-principle, which is imperative for industry to make a forward-looking decision to invest significant resources and develop it for commercial application.read more

Read the whole article on Harvard Science

More from Harvard Science

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net